Today: 4 June 2026
Palantir Stock Dips Despite Google AI News
4 June 2026

Palantir Stock Dips Despite Google AI News

Palantir shares fell 0.9% to $140.89 despite announcing a deeper Google Cloud partnership and new commercial deals at its AIPCon event, as investors weigh whether these moves will drive durable revenue growth amid ongoing valuation sensitivity, government-contract scrutiny, and shareholder pressure.
Veru shares jump after Novo Nordisk deal draws traders

Veru shares jump after Novo Nordisk deal draws traders

4 June 2026
Veru shares soared 112% to $4.78 after announcing Novo Nordisk will supply Wegovy at no charge for Veru’s Phase 2b obesity trial, with Veru retaining global rights to enobosarm but granting Novo a right of first negotiation; analysts called the deal a “significant event” and kept $24–$25 targets, while Veru warned trial risks and reimbursement challenges remain.
AT&T shares slip as SpaceX Starlink threat rattles analysts

AT&T shares slip as SpaceX Starlink threat rattles analysts

AT&T shares held near $23.55 after a 4.4% drop tied to fears over SpaceX’s $135-a-share Starlink IPO and its potential $1.75 trillion valuation, as Oppenheimer downgraded AT&T citing risk to broadband growth from Starlink’s expanding, lower-priced satellite internet, while AT&T counters with new fiber offerings and bundles ahead of key investor updates.
IREN Up Early as 800MW AI Campus in Australia Heats Up Power Race

IREN Stock Moves Early as Market Reacts to Australia AI Data-Center Push

IREN Ltd. shares dropped 5.8% in extended trading to $61.66 after announcing an 800MW Australian data-center campus, despite a $3.65B GPU financing deal and major contracts with Microsoft and Nvidia; Q3 revenue fell to $144.8M with a $247.8M net loss, as investors weigh growth ambitions against execution, bitcoin prices, and project risks.
Marvell Shares Set New High With Nvidia Surge Lifting Chip Suppliers

Marvell Shares Set New High With Nvidia Surge Lifting Chip Suppliers

Marvell soared to a record $301.65 close after Nvidia CEO Jensen Huang called it the next “trillion-dollar company,” fueling an AI-led rally as investors reprice Marvell for its data-center networking and custom chip growth; record Q1 revenue and raised forecasts add momentum, but Morningstar warns the stock now trades well above its $235 fair value estimate with “High” uncertainty.

Latest

Patterson-UTI Shares Up as Oil Slips

Patterson-UTI Shares Up as Oil Slips

Patterson-UTI Energy shares jumped 3.1% to $12.39, outpacing oil peers and the broader market, as the company forecast rising rig counts, higher dayrates, and $220 million in Q2 adjusted EBITDA, despite falling crude prices and a historic low in drilled-but-uncompleted shale wells, signaling strong demand for drilling activity.
ASML Trading Close to €1,500 After New Wall Street Backing

ASML Trading Close to €1,500 After New Wall Street Backing

ASML shares surged near €1,500 in Amsterdam after BofA and Barclays raised price targets, citing strong EUV tool demand and increased visibility from major chipmakers like TSMC, which confirmed ongoing AI-driven supply constraints; both brokerages warned that China export restrictions and weaker chip spending remain key risks.
Dow Jumps as Oil Drops; Wall Street Watches Broadcom AI Moves

Dow Jumps as Oil Drops; Wall Street Watches Broadcom AI Moves

Dow surges 1.6% to a record 51,496.83 as investors rotate into healthcare and financial stocks after Wednesday’s selloff, while Broadcom plunges 11.2% on missed revenue and flat AI-chip guidance, capping Nasdaq gains; oil drops 3% on Middle East ceasefire hopes, but risks from chip sector weakness and geopolitical tensions remain, Reuters reports.
ChronoScale Shares Jump After Tesla Alum Joins AI Compute Effort

ChronoScale Shares Jump After Tesla Alum Joins AI Compute Effort

ChronoScale shares soared nearly 18% to $22.43 after appointing ex-Tesla VP Raj Jegannathan as CTO and Lawrence Lam as CPO, just a month after its Nasdaq debut following a merger with Applied Digital’s cloud business and Ekso Bionics; Applied Digital and affiliates hold about 97% of shares, giving the company a $3.21 billion equity value, while investors weigh execution risks and integration challenges.
Blue Owl Shares Rise With Private-Credit Concerns Fading

Blue Owl Shares Rise With Private-Credit Concerns Fading

Blue Owl shares surged 5.5% to $10.225 as private-credit asset managers rebounded after Blackstone capped withdrawals at a major fund, easing investor fears about sector-wide redemption risks; Blue Owl’s own funds previously faced large withdrawal requests, and further negative updates could quickly reverse gains.
Oscar Health gains after Wells Fargo upgrade

Oscar Health gains after Wells Fargo upgrade

Oscar Health soared 15.5% to $23.68 after Wells Fargo upgraded the stock, citing improved 2026 health-exchange trends despite warning that visibility beyond this year remains low; the move outpaced rivals as traders bet on near-term stability, even as risks from expiring tax credits and policy changes linger.
Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Holdings’ U.S. shares jumped 2.9% to $3.51 as investors weighed strong Q1 results—revenue up 24% to $955 million, adjusted EBITDA up 46% to $154 million—and the consolidation of Indonesia’s Superbank, now majority-owned by Grab, against risks from higher fuel costs and regional regulation, leaving the stock sensitive to further updates on profitability and fintech growth.
Goldman Sachs Jumps as Dow Sets New High

Goldman Sachs Jumps as Dow Sets New High

Goldman Sachs shares surged 4.6% to $1,095.89, powering the Dow to an all-time high as investors rotated into financials; the move was amplified by Goldman’s high share price in the price-weighted Dow, while the bank’s lead role in the $75 billion SpaceX IPO and strong Q1 earnings added momentum, even as analysts flagged risks from high IPO valuations and geopolitical uncertainty.
Veru shares jump after Novo Nordisk deal draws traders

Veru shares jump after Novo Nordisk deal draws traders

Veru shares soared 112% to $4.78 after announcing Novo Nordisk will supply Wegovy at no charge for Veru’s Phase 2b obesity trial, with Veru retaining global rights to enobosarm but granting Novo a right of first negotiation; analysts called the deal a “significant event” and kept $24–$25 targets, while Veru warned trial risks and reimbursement challenges remain.
CRISPR Therapeutics Jumps 12% in New York Trading

CRISPR Therapeutics Jumps 12% in New York Trading

CRISPR Therapeutics shares soared 11.7% to $58.15 after presenting at the Jefferies Global Healthcare Conference, with sector momentum lifting gene-editing stocks and the SPDR S&P Biotech ETF up 3.0%. Casgevy, its key sickle cell therapy, posted $43 million Q1 revenue, but a $122.9 million net loss and biotech risks mean the rally hinges on investor appetite and upcoming clinical updates.
High demand wipes out U.S. Mint $5,370 gold coin in minutes

High demand wipes out U.S. Mint $5,370 gold coin in minutes

The U.S. Mint’s new $5,370 one-ounce American Eagle gold coin sold out in under two minutes, highlighting surging demand for physical gold investment, which Metals Focus says will overtake jewelry as the top gold demand driver this year; spot gold rose 1.7% to $4,505.35, but analysts warn high rates and a stronger dollar could pressure prices and premiums.
04 Jun
PVH Drops Hard as Calvin Klein Parent Issues Warning

PVH Drops Hard as Calvin Klein Parent Issues Warning

PVH shares plunged 21% after the company slashed its annual sales outlook, blaming the Middle East conflict for a 5% EMEA revenue drop; despite beating first-quarter earnings estimates, the warning erased over a fifth of PVH’s market value as investors focused on EMEA demand risks, with the region making up 47% of sales.
Go toTop